Fatigue as a symptom of neurological diseases

Abstract

Objective. The aim of the work was to study the fatigue syndrome in various organic brain diseases.

Materials and methods. Patients in the recovery period of hemispheric stroke, with Parkinson's disease and multiple sclerosis were examined. Along with the clinical one, there was conducted a study using the asthenia questionnaire MFI-20, FIS (Fatigue Impact Scale), FSS (Fatigue Severity Scale).

Results. It has been established that patients with various diseases of the central nervous system have a syndrome of fatigue, which is a nosogenic one, that is, a consequence of organic brain damage.

Keywords

stroke / Parkinson's disease / multiple sclerosis / fatigue syndrome

References

[1] Nodel' M.R. Fatigue in Parkinson's disease. Zhurnal nevrologii i psihiatrii imeni S.S. Korsakova 2009; 9: 23–26 (in Russian).

[2] Нодель М.Р. Утомляемость при болезни Паркинсона. Журнал неврологии и психиатрии имени С.С. Корсакова 2009; 9: 23–26.

[3] Lou J.S. Kearns G., Oken V. et al. Exacerbated physical and mental fatigue in Parkinsons disease. Mov Dis 2001;16: 190–196.

[4] Lou J.S. Kearns G., Oken В. et al. Exacerbated physical and mental fatigue in Parkinsons disease. Mov Dis 2001;16: 190–196.

[5] Chaudhuri A., Behan P.O. Fatigue in neurological disorders. The Lan-cet 2004; 363: 978–986.

[6] Chaudhuri A., Behan P.O. Fatigue in neurological disorders. The Lancet 2004; 363: 978–986.

[7] Bajdina T.V. Inflammatory mechanisms of atherosclerotic lesions of the main arteries of the head in the development of atherothrombotic stroke and the possibility of their therapeutic correction with statins: avtoref. dis. … d-ra med. nauk. Perm' 2006 (in Russian).

[8] Байдина Т.В. Воспалительные механизмы атеросклеротического поражения магистральных артерий головы в развитии атеротромботического инсульта и возможности их терапевтической коррекции статинами: автореф. дис. … д-ра мед. наук. Пермь 2006.

[9] Levin O.S., Fedorova N.V., SHtok V.N. Differential diagnosis of parkinsonism. Zhurnal nevrologii i psihiatrii imeni S.S. Korsakova 2003; 3: 54–60 (in Russian).

[10] Левин О.С., Федорова Н.В., Шток В.Н. Дифференциальная диагностика паркинсонизма. Журнал неврологии и психиатрии имени С.С. Корсакова 2003; 3: 54–60.

[11] Chaudhuri A., Behan P.O. Fatigue and basal ganglia. J Neurol Sci 2000; 179: 34–42.

[12] Mendonça D.A., Menezes K, Jog M.S. Methylphenidate improves fatigue scores in Parkinson disease: a randomized controlled trial. Movement Disorders 2007; 22 (14): 2070–2076.

[13] Mendonça D.A., Menezes K, Jog M.S. Methylphenidate improves fatigue scores in Parkinson disease: a randomized controlled trial. Movement Disorders 2007; 22(14): 2070–2076.

[14] Akinceva YU.V., Bajdina T.V. Platelet serotonin in patients with multiple sclerosis. Vrachaspirant 2011; 4 (5.4): 614–619 (in Russian).

[15] Акинцева Ю.В., Байдина Т.В. Тромбоцитарный серотонин у больных рассеянным склерозом. Врач-аспирант 2011; 4 (5.4): 614–619.

[16] Bajdina T.V., Torgan T.I., Demchuk N.D., Danilova M.A. Inflammatory mechanisms of fatigue syndrome formation in Parkinson's disease. Zhurnal nevrologii i psihiatrii im. C.C. Korsakova 2015; 115(3): 61–64 (in Russian).

[17] Байдина Т.В., Торган Т.И., Демчук Н.Д., Данилова М.А. Воспалительные механизмы формирования синдрома усталости при болезни Паркинсона. Журнал неврологии и психиатрии им. C.C. Корсакова 2015; 115 (3): 61–64.

RIGHTS & PERMISSIONS

Baidina T.V., Kolesova T.I., Malinina Y.V., Trushnikova T.N., Danilova M.A.